Status:
COMPLETED
MC-5A for Chemotherapy Induced Peripheral Neuropathy
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Neuropathy, Paraneoplastic
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Painful chemotherapy induced peripheral neuropathy (CIPN) is a common complication of cancer therapy with few treatment options. CIPN is a complex side effect that varies between individuals and can b...
Eligibility Criteria
Inclusion
- painful peripheral neuropathy resulting from chemotherapy
- pain must be present for minimum of 6 months
- must be able to read/understand English
- stable analgesics regimens allowed (no change for past 7 days)
Exclusion
- painful peripheral neuropathy that is not the result of chemotherapy
- pregnant women
- patients unable to wean off anti-epileptics
- patients currently receiving chemotherapy known to cause peripheral neuropathy
- patients with pacemakers or implanted defibrillators
- patients with vena cava or aneurysm clips
- patients with a history of epilepsy
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01261780
Start Date
April 1 2011
End Date
September 1 2012
Last Update
December 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States, 53792